Our data suggest that higher serum myostatin levels are associated with lower insulin sensitivity in otherwise healthy adults, aged 20–65 years, with overweight/obesity, independent of other risk factors known to be associated with insulin resistance, namely BMI, visceral adiposity, and sex. The gene discussed is MSTN; the disease is obesity disorder.